Cases of the emerging coronavirus, COVID-19, increased in the world by 11% last week, due to the rise in the most widespread infection, Omicron in many countries, despite the decrease in deaths globally by 4%., which seems to refer to a Less severe for many infections with the new breed.
According to the weekly epidemiological report of the World Health Organization, From December 20 to 26, 4.9 million cases were confirmed on the planet, the highest number in nearly seven monthsWhile the deceased was 44,000, a number very similar to the number recorded each week for the past three months.
America was the region with the highest increase in cases last week, at 39% (1.4 million), while Europe topped the list in absolute numbers, with 2.8 million infections., 3% more than the previous seven days.
in a Africa, where infections doubled in the previous weeks, this time there was a moderate increase in cases, from 7% (274,000), At the same time Cases in East Asia remained stable (238,000), decreased in the Middle East by 3% (76,000) and in South Asia by 12% (76,000).
Despite the overall decrease in the number of deaths, there were Alarming 72% increase in deaths from COVID-19 in Africa (952), although in absolute numbers this figure was much lower than the deaths in Europe (23900, 12% less than the previous week) and in America (12,700, 7% more).
And the United States was the country that confirmed the largest number of injuries last week (1.1 million, 34% more), followed by the United Kingdom (611.000, 20% more), France (504,000, 41% more) and Italy (257.000, 62% more).
On the positive side, in Germany, one of the first countries to suffer from the current wave of infections, fell by 30% In the seven days he studied and reached 197000, and in South Africa, the first country to discover the Omicron variant, the decrease was 29% Compared to the previous week (115000 positive).
Regarding the global vaccination campaign against COVID-19, 9,000 million vaccines have been administered, with 57% of the world’s population having received at least one dose, although this percentage drops to 8% in low-income countries.
(With information from EFE)